ANAVIC MEDICAL
0890.063.189 · rovalta.com · 24/09/2026
NORMAL SITUATION
ANAVIC MEDICAL
Company — Normal situation.
Financial year 2022 · Closed on 30/12/2022
Net result
1,4 M €
+7 891,6 %over 1 yearGross margin
-16,1 k €
+1,0 %over 1 yearEquity
1,9 M €
+237,1 %over 1 yearOverview
Identity
Source · BCE/KBOANAVIC MEDICAL is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0890.063.189
- Legal form
- Public limited company
- Contributed capital
- 62 500,00 €
- Latest accounts
- 30/12/2022
Signals
ProfitableSolid equityPositive cashflow
Financials
Source · NBB, 15 filingsTrend over 14 financial years
| 2022 | 2021 | 2019 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -16,1 k € | +1.0% | -16,3 k € | -338% | 6,8 k € | +121% | -32,8 k € | -200% | 32,7 k € |
| EBITDA | -17 k € | +5.9% | -18 k € | -409% | 5,8 k € | +118% | -32,8 k € | -301% | 16,3 k € |
| Operating result | -17 k € | +5.9% | -18 k € | -570% | 3,8 k € | +111% | -34,8 k € | -313% | 16,3 k € |
| Net result | 1,4 M € | +7892% | -17,4 k € | -117% | 103,8 k € | +189% | 35,9 k € | +243% | -25,1 k € |
| Balance sheet | |||||||||
| Equity | 1,9 M € | +237% | 573,1 k € | +3.0% | 556,2 k € | +22.9% | 452,4 k € | +8.6% | 416,5 k € |
| Total assets | 1,9 M € | +143% | 796,4 k € | -0.7% | 802 k € | -1.1% | 811 k € | +1.4% | 799,5 k € |
| Cash | 804,6 € | -91.7% | 9,6 k € | +54.5% | 6,2 k € | -21.3% | 7,9 k € | -18.1% | 9,7 k € |
| Debts | 0 € | -100% | 223,3 k € | -9.2% | 245,8 k € | -31.5% | 358,6 k € | -6.4% | 383 k € |
Board of directors
Source · NBB, accounts to 30/12/20223 active · 6 ended
Active mandates
France Clément
ActiveBrice Tirvert
ActivePascal Guerin
ActiveEnded mandates
Brice Tirvert
EndedAlexandre DUBUS
EndedAlexandre DUBUS
EndedAlexandre DUBUS
EndedFinancials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 30/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 07/07/2023 | 20/07/2022 | 27/08/2021 | 02/07/2020 | 30/08/2019 | 30/08/2018 |
| General meeting | 30/12/2022 | 24/06/2022 | 15/07/2021 | 24/06/2020 | 28/08/2019 | 16/08/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/12/2022 | 30/12/2022 | 07/07/2023 | French | |
| Abridged model | 31/12/2021 | 24/06/2022 | 20/07/2022 | French | |
| Abridged model | 31/12/2020 | 15/07/2021 | 27/08/2021 | French | |
| Micro model | 31/12/2019 | 24/06/2020 | 02/07/2020 | French | |
| Micro model | 31/12/2018 | 28/08/2019 | 30/08/2019 | French | |
| Micro model | 31/12/2017 | 16/08/2018 | 30/08/2018 | French | |
| Micro model | 31/12/2016 | 15/07/2017 | 31/08/2017 | French | |
| Abridged model | 31/12/2015 | 20/08/2016 | 29/08/2016 | French | |
| Abridged model | 31/12/2014 | 22/08/2015 | 31/08/2015 | French | |
| Abridged model | 31/12/2013 | 16/08/2014 | 29/08/2014 | French | |
| Abridged model | 31/12/2012 | 17/08/2013 | 28/08/2013 | French | |
| Abridged model | 31/12/2011 | 18/08/2012 | 31/08/2012 | French | |
| Abridged model | 31/12/2010 | 20/08/2011 | 18/11/2011 | French | |
| Abridged model | 31/12/2009 | 26/06/2010 | 23/07/2010 | French | |
| Abridged model | 31/12/2008 | 20/06/2009 | 24/07/2009 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/12/20223 active · 6 ended
Active mandates
France Clément
ActiveBrice Tirvert
ActivePascal Guerin
ActiveEnded mandates
Brice Tirvert
EndedAlexandre DUBUS
EndedAlexandre DUBUS
EndedAlexandre DUBUS
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution15/02/2023RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
- Mandates27/01/2023DEMISSIONS, NOMINATIONS
- Mandates07/09/2022DEMISSIONS, NOMINATIONS
- Registered office21/06/2022SIEGE SOCIAL
- Registered office13/10/2021SIEGE SOCIAL
- Registered office03/02/2021SIEGE SOCIAL
- Mandates21/12/2020DEMISSIONS, NOMINATIONS
- Mandates09/07/2020CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 20221,4 M €↑
- 2022Name changeAnavic Medical en liquidation
- 2021Annual accounts 2021-17,4 k €↓
- 2021Name changeAnavic Medical
- 2019Annual accounts 2019103,8 k €↑
- 2018Annual accounts 201835,9 k €↑
- 2017Annual accounts 2017-25,1 k €↓
- 2016Annual accounts 201642,3 k €↑
- 2015Annual accounts 201512,8 k €↓
- 2014Annual accounts 201416,2 k €↓
- 2013Annual accounts 201326,6 k €↑
- 2012Annual accounts 201215,3 k €↓
- 2011Annual accounts 201116,1 k €↓
- 2010Annual accounts 201019,7 k €↓
- 2009Annual accounts 200960,9 k €↓
- 2008Annual accounts 2008169,1 k €